Ero1l Mouse shRNA Plasmid (Locus ID 50527)
CAT#: TR502816
Ero1l - Mouse, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 4 publications. |
Product images
经常一起买 (1)
Specifications
Product Data | |
Product Name | Ero1l Mouse shRNA Plasmid (Locus ID 50527) |
Locus ID | 50527 |
UniProt ID | Q8R180 |
Synonyms | Er; ERO1-L; Ero1l |
Vector | pRS |
Format | Retroviral plasmids |
Kit Components | Ero1l - Mouse, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 50527). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free. |
RefSeq | BC025102, NM_015774, NM_015774.1, NM_015774.2, NM_015774.3 |
Summary | This gene encodes a member of the endoplasmic reticulum oxidoreductin family. The encoded protein is localized to the endoplasmic reticulum and promotes the formation of disulfide bonds by oxidizing protein disulfide isomerase. This gene may play a role in endoplasmic reticulum stress-induced apoptosis and the cellular response to hypoxia. [provided by RefSeq, Feb 2011] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (4)
The use of this RNAi has been cited in the following citations: |
---|
Hypoxia augments MHC class I antigen presentation via facilitation of ERO1-a-mediated oxidative folding in murine tumor cells
,Kajiwara, T;Tanaka, T;Kukita, K;Kutomi, G;Saito, K;Okuya, K;Takaya, A;Kochin, V;Kanaseki, T;Tsukahara, T;Hirohashi, Y;Torigoe, T;Hirata, K;Sato, N;Tamura, Y;,
Eur. J. Immunol.
,PubMed ID 27667124
[ERO1a]
|
Cancer-Associated Oxidase ERO1-α Regulates the Expression of MHC Class I Molecule via Oxidative Folding.
,null,
Journal of immunology (Baltimore, Md. : 1950)
,PubMed ID 25870246
[Ero1a]
|
Cancer-associated oxidoreductase ERO1-α drives the production of tumor-promoting myeloid-derived suppressor cells via oxidative protein folding.
,null,
Journal of immunology (Baltimore, Md. : 1950)
,PubMed ID 25595776
[Ero1a]
|
Human endoplasmic reticulum oxidoreductin 1‐α is a novel predictor for poor prognosis of breast cancer
,null,
Cancer Science
,PubMed ID 23578220
[Ero1a]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...